MEDX ETF Profile

Family:	Horizon Kinetics
Name:	Horizon Kinetics Medical ETF

Inception Date:	27-Jan-2023
Termination Date:
Investment Objective:	Horizon Kinetics Medical ETF is an actively-managed exchange-traded fund ("ETF") that pursues its investment objective of investing, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants and other equity securities having the characteristics of common stocks (such as American Depositary Receipts ("ADRs"), Global Depositary Receipts ("GDRs") and International Depositary Receipts "IDRs")) of U.S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries, generally, with an emphasis toward companies engaged in cancer research and drug development, such as pharmaceutical development companies, surgical and medical instrument manufacturers and developers, pharmaceutical manufacturers, and biotech and medical research companies. These companies derive at least 50% of their revenue from such activities. The Fund also may invest in other ETFs and purchase and write options for hedging purposes and/or direct investment.

Prospectus

Number of Holdings:	37
Shares Outstanding:	594,946
Total Net Assets:	16,575,730
NAV:	27.86
Net Expense Ratio:	0.85%

Asset Class:	Equities (Stocks)
Developed or Emerging:	Funds Combining Developed & Emerging Exposure
Country:
Region:
Strategy:
Currency:
Commodity:
Sector:	Healthcare
Industry:
Dividend Type:
Tax Exempt State:
Maturity Duration:
Market Cap:	Broad Market / Multi-Cap
Credit Quality:
Mortgage Bond Types:
Bond Type:
Gov't Bond Types:
Reit Type:
Leverage Direction/Factor:
Is Currency Hedged:	No
US or Ex-US:	Global